Trials / Unknown
UnknownNCT02230436
Early Versus Late Drain Removal After Pancreatectomy: A Randomized Prospective Trial
The Impact of Early Versus Late Drain Removal on Postoperative Morbidity After Pancreatectomy: A Randomized Prospective Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 144 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to demonstrate the hypothesis that early removal of drain can reduce the incidence of intra-abdominal infection and pancreatic fistula after pancreatectomy compared with later removal of drain.
Detailed description
This study is to analyze the association between the time of removal of drain after pancreatic resection and incidence of intra-abdominal complications, such as intra-abdominal infection and pancreatic leakage. We design a prospective randomized study. Patients with pancreatic and periampullar tumors who underwent pancreatoduodenectomy (PD) or distal pancreatectomy (DP) are recruited to the study if amylase value in drain(s) is less than 5000 U/L on postoperative day (POD) 1. After obtaining informed consent, eligible patients are randomly allocated to early or late drain removal group on POD 3. In the group A, drain(s) are removed on POD 3, whereas in group B drain is removed on POD 4 or beyond. The primary outcomes are the incidence of intra-abdominal infection and pancreatic fistula; the secondary outcomes include intra-abdominal bleeding, delayed gastric emptying, pulmonary complications, and length of hospital stay.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Early drain removal | Removing drain(s) on postoperative day 3 |
| OTHER | Late drain removal | Removing drain(s) on postoperative day 4 or later |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2017-07-01
- Completion
- 2017-12-01
- First posted
- 2014-09-03
- Last updated
- 2017-02-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02230436. Inclusion in this directory is not an endorsement.